Following the voluntary withdrawal of infant cold and cough medications from the U.S. market in 2007, children younger than 2 years accounted for 2.4% of all emergency department visits for suspected adverse reactions to the drugs, down from 4.1% prior to the withdrawal, CDC researchers said. ED visits associated with the medications also dropped among 2- to 3-year-olds from 9.5% to 6.5% after manufacturers added labels warning that such medications should not be given to children younger than 4, according to a report published Monday in the journal Pediatrics.

Related Summaries